ALEMBICLTDNSEAlembic Limited· PharmaceuticalsHighPositive
Announced Tue, 19 May · 18:06 IST

Alembic Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2026, recommended Final Dividend of Rs. 2.40 per equity share.

Corporate Actions View source PDF

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹89.70
prior close
₹87.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.4+0.5+0.7-2.5-2.5-1.9-1.5-2.9-3.2-4.3+2.1+0.9
Up moveDown movePending
AI summary

Alembic Limited's Board recommended a final dividend of Rs. 2.40 per equity share (120% on face value of Rs. 2/-) for FY2026, subject to shareholder approval at the ensuing AGM. This is unchanged from the previous year's dividend of Rs. 2.40 per share. Standalone net profit declined to Rs. 12,454 lakhs from Rs. 14,195 lakhs (down ~12%), while consolidated net profit after accounting for associate share slightly increased to Rs. 31,738 lakhs (vs Rs. 31,068 lakhs). Total standalone revenue grew to Rs. 23,193 lakhs from Rs. 21,436 lakhs. The company operates in Active Pharmaceutical Ingredients and Real Estate segments. Auditors issued an unmodified opinion on both standalone and consolidated financial statements.

Likely market impact

The unchanged dividend despite lower standalone earnings signals management confidence, but the declining standalone profit may raise concerns. The stock may see neutral to slightly negative reaction given the profit decline, though the dividend provides some support to investor sentiment.